A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is associated with increased cardiovascular morbidity and mortality. Elevated arterial stiffness, measured by aortic pulse wave velocity (aPWV), is a cardiovascular risk surrogate and is potentially modifiable by inhaled corticosteroid/long-...

Full description

Saved in:
Bibliographic Details
Published in:Int J Chron Obstruct Pulmon Dis
Main Authors: Bhatt, Surya P, Dransfield, Mark T, Cockcroft, John R, Wang-Jairaj, Jie, Midwinter, Dawn A, Rubin, David B, Scott-Wilson, Catherine A, Crim, Courtney
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2017
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5261599/
https://ncbi.nlm.nih.gov/pubmed/28176907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S117373
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items